J9282 NDC Crosswalk, Billing Units, ASP Payment & Medicare Reimbursement

📋 J9282 summary

J9282 is a HCPCS Level II J-code used to bill Mitomycin intravesical inst, billed per 1 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J9282: Zusduri

Code J9282 Billing unit 1 MG Payment limit $274.342/unit NDC-Crosswalk 1 Quarter Q3 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ9282

DescriptorMitomycin intravesical inst

Billing unit1 MG

Payment limit / unit$274.342

Est. ASP / unit$258.813 est.

Mapped NDCs1

Data periodQ3 2026

Last updated2026-09-20

💊 About Mitomycin DRUG GUIDE

The use depends on the product.

Mitomycin and Mutamycin (intravenous injection) are used with other approved chemotherapy drugs for disseminated (spread) adenocarcinoma of the stomach or pancreas.

They are also used as palliative treatment (to ease the disease) when other approaches have failed.Other mitomycin products have different uses.

Zusduri is for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.

Read the full Mitomycin drug guide →

Clinical overview from our editorial drug guide for Mitomycin. For billing reference, see the sections above.

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026

📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).

Medicare payment limit / unit

$274.342

Est. ASP / unit

$258.813 est.

Est. after 2% sequester

$268.855

HCPCS dosage

1 MG

The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J9282 = 1 mg. Enter a regimen to convert dose → billing units and project a full course.

Dose per administration (mg) Frequency — every days Number of doses NDC / package billed (optional)

Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J9282 WITH EST. MEDICARE PAY

1 NDC map to J9282. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($274.342/unit) × that package's bill units.

NDC (11-digit)	Drug	Labeler	Package	Strength	Bill units	Est. pay / pkg	NADAC / unit	Status	Source
72493-0106-03	ZUSDURI Mitomycin KIT	UroGen	1 KIT in 1 CARTON (72493-106-03) * 1 POW...	—	80	$21,947.36	—	● Active	CMS ASP

NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

⚠️ Don't confuse J9282 with… RELATED CODES

Adjacent HCPCS codes that share an ingredient or formulation with J9282. Billing units and payment limits differ — confirm the exact code, strength and form before billing.

Code	Descriptor	Billing unit	Payment limit / unit	How it differs from J9282
J9281	Mitomycin instillation	1 MG	$329.937	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J9280	Mitomycin injection	5 MG	$34.107	Different billing unit — 5 MG vs 1 MG

Related codes matched on shared ingredient (CMS Medicare Part B Spending feed). Billing units and payment limits from the CMS ASP Pricing File. Always verify the precise HCPCS code for the product and strength administered.

📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)

Total Part B spend

$14.54M

Claims

747

Beneficiaries

228

Spend / beneficiary

$63,760.46

Spend / claim

$19,461.02

Where J9282 ranks among Part B drugs · 2026 (Q1) · neighbors ±5

Total spending — #149 of 824

#144 MONOVISC J7327 $15.25M #145 DESCOVY J0751 $15.17M #146 FULPHILA Q5108 $15.02M #147 FLUAD * 90653 $15.02M #148 EXPAREL J0666 $15.01M #149 ZUSDURI J9282 $14.54M #150 BOMYNTRA* Q5158 $14.42M #151 IMJUDO J9347 $14.18M #152 HERCEPTIN J9355 $13.84M #153 LEVULAN J7308 $13.55M #154 MEMBRANE GRAFT OR WR... Q4205 $13.47M

Total claims — #405 of 824

#400 APLIGRAF Q4101 777 #401 FULVESTRANT J9394 769 #402 DEFEROXAMINE MESYLAT... J0895 762 #403 XCEED TL MATRIX PER... Q4353 760 #404 CIMERLI Q5128 759 #405 ZUSDURI J9282 747 #406 FOSAPREPITANT DIMEGL... J1456 743 #407 PURAPLY XT 1 SQ CM** Q4197 731 #408 ACETAMINOPHEN(J0131) J0131 726 #409 ENGERIX-B ADULT(9074... 90740 724 #410 GAMMAPLEX J1557 711

Full breakdown by period (1)

Period	Total spend	Beneficiaries	Claims	$/beneficiary	$/claim
2026 (Q1)	$14.54M	228	747	$63,760.46	$19,461.02

Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.

🗺️ Where J9282 is utilized

⏳

The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.

HCPCS code & descriptor

CMS HCPCS Level II code file

Not available in current dataset

Payment limit & billing unit

CMS Medicare Part B ASP Pricing File (quarterly)

Q3 2026 · as of 2026-09-20

NDC ↔ HCPCS crosswalk

CMS ASP NDC-HCPCS crosswalk

1 NDC mapped

NADAC acquisition cost

CMS National Average Drug Acquisition Cost (weekly)

Not available for mapped NDCs

Utilization & spend

CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners

Latest data year 2026

Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J9282 billing FAQ

What is HCPCS code J9282?

J9282 is a HCPCS Level II J-code used to bill Mitomycin intravesical inst under Medicare Part B and most medical (not pharmacy) benefits.

What is the billing unit for J9282?

One unit of J9282 represents 1 MG. Report the number of units equal to the dose administered divided by 1 MG.

How many units of J9282 should I bill?

Divide the dose administered by the code's unit size (1 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.

How much does Medicare pay for J9282?

The Medicare Part B payment limit is $274.342 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $268.855 per unit. Payment limits are revised quarterly.

Which NDCs bill under J9282?

1 NDC currently map to J9282 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.

Does a crosswalk mean J9282 is covered?

No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.

J9282 – Mitomycin intravesical inst · NDC Crosswalk & Billing Units